Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Inflammation is at the origin and progression of diseases such as diabetes or cancer

18.06.2007
IRB Barcelona and Fundación BBVA have invited fifteen international researchers to discuss new scientific evidence associating chronic inflammation with a long list of diseases. Cancer and diabetes are the latest additions to this list.

What is the role of inflammation in cancer? Which molecular and cell mechanisms promote inflammation? How do antiinflammatory agents work and which molecules do we need to target for antiinflammatories to be more effective? These are essential questions for scientists studying the mechanisms that activate and control innate immune response. Fifteen top international specialists in this field will gather from 25-27 June for a conference entitled, “Inflammation and Chronic Disease”, part of the “Barcelona BioMed” conference series organised by the Institute for Research in Biomedicine (IRB Barcelona) and the Fundación BBVA. The event will be hosted by the Institut d’Estudis Catalans (IEC).

Inflammation and Chronic Disease

Inflammation is the innate response of the immune system that occurs when an organism sustains a lesion or infection. When the damaged tissue heals, the inflammation disappears, but when the inflammation remains active and becomes chronic, it can severely damage the affected tissue.

... more about:
»Diabetes »IRB »mechanisms

Asthma, rheumatoid arthritis, inflammatory bowel disease, psoriasis, multiple sclerosis, Alzheimer’s disease and, most recently, type 2 diabetes and cancer, are diseases that have been associated with chronic inflammation. Carme Caelles, researcher at IRB Barcelona and co-organiser of the conference, explains that “until recently inflammation has been considered simply a side effect of cancer. In the last three years, however, growing evidence has pointed to the active role of inflammation not just at the beginning but also in the promotion and progression of the disease”.

Inflammation is also linked to obesity and type 2 diabetes. The presence of excessive fat activates the production of cytokines, proteins involved in inflammatory processes that end up promoting insulin resistance. There are currently several drugs in clinical testing that inhibit cytokines as a treatment for diabetes. “Not all anti-inflammatory drugs work for all diseases. The challenge is to identify and understand complete mechanisms so that the most effective drugs can be designed for each disease, with the fewest side effects possible”, points out Caelles.

The conference will host a full range of specialists and will cover a variety of areas. Speakers will present their research into the basic mechanisms that activate inflammation, as well as the results from other studies directly associated with the disease. Michael Karin, co-organiser of the event and researcher at the University of California San Diego (USA), for example, published with his team a conclusive study linking inflammation, infection and cancer in Nature earlier this year. Another internationally renowned scientist is Gabriel Nuñez, from the University of Michigan Medical School (USA), whose laboratory has been studying the “autoinflammatory syndrome”. Jorge Moscat, from Genome Research Institute (USA), is a leading expert in signal transduction processes during the inflammatory response. Antonio Celada, an immunologist at IRB Barcelona, will present the latest results of his team on macrophages, cells that play a key role in the body’s immune response.

Sònia Armengou | alfa
Further information:
http://www.pcb.ub.es
http://www.irbbarcelona.org

Further reports about: Diabetes IRB mechanisms

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>